Author
Listed:
- Praveena S. Thiagarajan
(Cleveland Clinic
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University)
- Maksim Sinyuk
(Cleveland Clinic)
- Soumya M. Turaga
(Cleveland Clinic)
- Erin E. Mulkearns-Hubert
(Cleveland Clinic)
- James S. Hale
(Cleveland Clinic)
- Vinay Rao
(Cleveland Clinic)
- Abeba Demelash
(Cleveland Clinic)
- Caner Saygin
(Cleveland Clinic)
- Arnab China
(Cleveland Clinic)
- Tyler J. Alban
(Cleveland Clinic
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University)
- Masahiro Hitomi
(Cleveland Clinic
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University)
- Luke A. Torre-Healy
(Cleveland Clinic)
- Alvaro G. Alvarado
(Cleveland Clinic)
- Awad Jarrar
(Cleveland Clinic)
- Andrew Wiechert
(Cleveland Clinic)
- Valery Adorno-Cruz
(Case Comprehensive Cancer Center
Case Western Reserve University
Northwestern University School of Medicine)
- Paul L. Fox
(Cleveland Clinic
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Case Comprehensive Cancer Center)
- Benjamin C. Calhoun
(Cleveland Clinic)
- Jun-Lin Guan
(University of Cincinnati)
- Huiping Liu
(Case Comprehensive Cancer Center
Case Western Reserve University
Northwestern University School of Medicine)
- Ofer Reizes
(Cleveland Clinic
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Case Comprehensive Cancer Center)
- Justin D. Lathia
(Cleveland Clinic
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Case Comprehensive Cancer Center)
Abstract
Tumors adapt their phenotypes during growth and in response to therapies through dynamic changes in cellular processes. Connexin proteins enable such dynamic changes during development, and their dysregulation leads to disease states. The gap junction communication channels formed by connexins have been reported to exhibit tumor-suppressive functions, including in triple-negative breast cancer (TNBC). However, we find that connexin 26 (Cx26) is elevated in self-renewing cancer stem cells (CSCs) and is necessary and sufficient for their maintenance. Cx26 promotes CSC self-renewal by forming a signaling complex with the pluripotency transcription factor NANOG and focal adhesion kinase (FAK), resulting in NANOG stabilization and FAK activation. This FAK/NANOG-containing complex is not formed in mammary epithelial or luminal breast cancer cells. These findings challenge the paradigm that connexins are tumor suppressors in TNBC and reveal a unique function for Cx26 in regulating the core self-renewal signaling that controls CSC maintenance.
Suggested Citation
Praveena S. Thiagarajan & Maksim Sinyuk & Soumya M. Turaga & Erin E. Mulkearns-Hubert & James S. Hale & Vinay Rao & Abeba Demelash & Caner Saygin & Arnab China & Tyler J. Alban & Masahiro Hitomi & Luk, 2018.
"Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase,"
Nature Communications, Nature, vol. 9(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-02938-1
DOI: 10.1038/s41467-018-02938-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-02938-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.